ArticleJournal of immunotherapy and precision oncology2024

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma.

Mohamed A Gouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.